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Abstract: In this study, we examined the cytotoxic effects of curcumin, the yellow pigment 
of  Curcuma longa, on the blastocyst stage of mouse embryos, subsequent embryonic 
attachment, and outgrowth in vitro and in vivo implantation by embryo transfer. Mouse 
blastocysts were incubated in medium with or without curcumin (6, 12 or 24 μM) for 24 h. 
Cell proliferation and growth were investigated using dual differential staining, apoptosis 
was analyzed with terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling 
(TUNEL), and implantation and post-implantation development of embryos were measured 
by in vitro development analysis and in vivo embryo transfer, respectively. Blastocysts 
treated with 24 μM curcumin displayed significantly increased apoptosis and decreased total 
cell number. Interestingly, we observed no marked differences in the implantation success 
rates between curcumin-pretreated and control blastocysts during in vitro embryonic 
development through implantation with a fibronectin-coated culture dish. However, in vitro 
treatment with 24 μM curcumin was associated with decreased implantation rate and 
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increased resorption of postimplantation embryos in mouse uterus, as well as decreased fetal 
weight in the embryo transfer assay. Our results collectively indicate that in vitro exposure to 
curcumin triggers apoptosis and retards early postimplantation development after transfer to 
host mice. In addition, curcumin induces apoptotic injury effects on mouse blastocysts 
through ROS generation, and further promotes mitochondria-dependent apoptotic signaling 
processes to impair sequent embryonic development. 
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1. Introduction 
Curcumin, a common dietary pigment and spice, is a hydrophobic polyphenol derived from the 
rhizome of the herb Curcuma longa that is used as a traditional Indian medicine [1] for the treatment 
of wounds, liver ailments, hepatitis and urinary tract diseases, as well as a cosmetic compound [2]. 
Curcumin exerts a wide range of pharmacological effects, including anti-inflammatory, 
anti-carcinogenic, hypocholesterolemic and anti-infection activities [3-8]. As a potential antioxidant, 
curcumin displays anti-proliferative and anti-carcinogenic properties in a variety of cell lines and 
animals [8-12]. Moreover, the efficacy of curcumin in various diseases, including cancer, is well 
established [13]. Recent studies have shown that the anti-tumor activity of curcumin is attributed to its 
ability to induce apoptosis via caspase-3 activation [14,15]. Moreover, various in vivo animal assay 
models and human studies confirm that dietary curcumin is extremely safe and does not exert 
hazardous effects, even at high doses [16-19]. For example, three separate phase I clinical trials 
demonstrate that dietary curcumin administered at doses as high as 12 g per day is well tolerated 
[18-20]. Curcumin displays high pharmacological safety and efficacy, and is thus a potential candidate 
agent for the treatment and prevention of a wide range of human diseases. Importantly, a recent study 
by our group shows that curcumin inhibits methylglyoxal-induced reactive oxygen species (ROS) 
generation and various apoptotic biochemical events in embryonic stem cells and blastocysts isolated 
from pregnant mice [21]. Moreover, another study by our group focusing on the possible effects of 
curcumin on ROS generation, intracellular adenosine triphosphate (ATP) levels and cell death mode in 
osteoblast cells revealed that curcumin induces apoptosis or necrosis in a dose-dependent manner [15]. 
However, while multiple biological functions have been identified for curcumin, the ambiguous issue 
of its activity as an apoptotic inducer or inhibitor and the precise molecular mechanisms underlying 
these actions are yet to be fully determined. To date, virtually no studies have investigated the potential 
of curcumin as a cytotoxic agent against embryo development. 
Apoptosis plays important roles in development and disease [22]. While apoptosis is an established 
contributor to normal embryonic development [23-25], several other studies have shown that 
mechanistically diverse teratogens induce excessive apoptosis in early embryos, leading to 
developmental impairment [21,26-30]. Importantly, a recent investigation by our group revealed that 
curcumin induces apoptotic changes, including c-Jun N-terminal kinase (JNK) activation, caspase-3 Int. J. Mol. Sci. 2010, 11                 
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activation, and cleavage of poly-(ADP-ribose) polymerase (PARP) and p21-activated kinase 2 (PAK2) 
at treatment concentrations less than 25 μM in human osteoblast cells. In contrast, 50–200 μM 
curcumin did not induce apoptosis but triggered necrotic cell death in human osteoblasts [15]. In a 
further study, the curcumin dosage was show to determine its possible effects on ROS generation, 
intracellular ATP levels, and apoptosis or necrosis in osteoblast cells [15]. These findings collectively 
indicate that curcumin promotes apoptosis or necrosis in a dose-dependent manner in human osteoblast 
cells. To our knowledge, the present report is the first to show that the curcumin dosage significantly 
influences the cell death mode of osteoblasts. These novel findings provide important insights into the 
impact of curcumin on other mammalian cell lines, particularly in terms of embryonic stem cells or 
embryonic development.   
Here, we examined whether curcumin has cytotoxic effects and determined the related regulatory 
mechanisms in mouse embryonic development. Our results show that curcumin suppresses embryonic 
cell proliferation during the blastocyst stage predominantly by inducing apoptosis in the inner cell 
mass (ICM). We also monitored subsequent impairment of blastocyst development in vitro and 
following embryo transfer in vivo. However, the mechanisms underlying curcumin-induced apoptosis 
of mouse blastocysts remain to be determined. 
2. Results and Discussion 
To initially examine the possibility of curcumin-induced cytotoxicity, we treated mouse blastocysts 
with 6, 12 or 24 μM curcumin at 37 °C for 24 h, and monitored apoptosis using the TUNEL method. 
Curcumin clearly induced apoptosis in mouse blastocysts at a concentration of 24 μM (Figure 1A). 
Quantitative analysis revealed 7.5-fold higher apoptosis in curcumin-treated blastocysts versus 
untreated controls (Figure 1B), confirming curcumin-induced apoptosis in mouse blastocysts. 
Figure 1. Curcumin induces apoptosis in mouse blastocysts. (A) Mouse blastocysts were 
treated with curcumin (Cur; 6, 12 or 24 μM) for 24 h or left untreated, and apoptosis 
examined using TUNEL staining. The results were visualized using light microscopy. 
TUNEL-positive cells are depicted in black. (B) The mean number of apoptotic 
(TUNEL-positive) cells per blastocyst was calculated as five to eight determinations. 
Values are presented as means ± SEM. *** P < 0.001 versus the control group. 
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We further used differential staining for cell counting to examine proliferation in blastocysts treated 
with 6, 12 or 24 μM curcumin or left untreated for 24 h. The results revealed significantly lower total 
and ICM cell numbers in curcumin-treated blastocysts (24 μM) versus controls (Figure 2A). Annexin 
V and PI staining were further used to detect the cell death modes in ICM or TE or both. We observed 
significantly higher numbers of Annexin V-positive/PI-negative (apoptotic) cells in the ICM of treated 
blastocysts versus controls, but no differences in the TE (Figure 2B). Thus, it seems that curcumin 
induces significant apoptosis in the ICM but not TE of mouse blastocysts. These results further 
indicate that curcumin impairs the developmental potential of blastocysts by inducing ICM apoptosis. 
Figure 2. Effects of curcumin on blastocyst viability. Mouse blastocysts were treated with 
curcumin (Cur; 6, 12 or 24 μM) for 24 h or left untreated. (A) The total number of cells per 
blastocyst and cell numbers in the inner cell mass (ICM) and trophectoderm (TE) were 
counted. (B) The percentages of Annexin V-positive/PI-negative cells in the blastocysts of 
each group were examined. Data are based on at least 250 blastocyst samples from each 
group. Values are presented as means ± SEM of six determinations. *** P < 0.001 versus 
the control group. 
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We further analyzed the effects of curcumin on embryonic preimplantation, implantation and 
postimplantation development in vitro. Untreated control morulas displayed ~78% development into 
blastocysts, whereas only 32.5% of the 24 μM curcumin-treated morulas developed into blastocysts 
under our in vitro experimental conditions (Figure 3A). To analyze the effects of curcumin on 
implantation and postimplantation events in vitro, blastocysts were treated with 6, 12 or 24 μM 
curcumin (250–300 blastocysts for each group) or left untreated, and the implantation rate and 
subsequent development for 8 days in culture were analyzed. The implantation rate of and attachment 
to the fibronectin-coated dish were similar in the curcumin-treated group and the untreated control 
group (Figure 3B). Importantly, curcumin-pretreated blastocysts displayed a lower incidence of 
postimplantation developmental milestones compared with control blastocysts (Figure 3B). The results 
indicate that curcumin affects the in vitro potential of blastocysts to develop features of 
postimplantation embryos. Int. J. Mol. Sci. 2010, 11                 
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Figure 3. In vitro development of mouse embryos exposed to curcumin at the blastocyst 
stage. (A) Mouse morulas were treated with curcumin (Cur; 6, 12 or 24 μM) for 24 h or left 
untreated, and cultured for an additional 24 h at 37 °C. Blastocysts were counted and 
percentages calculated. (B) Mouse blastocysts were treated with curcumin (Cur, 6, 12 or 
24 μM) for 24 h or left untreated, and observed in culture for 7 days post-treatment. 
Blastocysts were identified as attachment only, ICM (+), ICM (++), and ICM (+++) via 
morphological assessment, as described in Materials and Methods. Values are presented as 
means ± SEM of eight determinations. *** P < 0.001 versus the control group. 
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To further determine the effects of curcumin on blastocyst development in vivo, we transferred 
mouse blastocysts subjected to curcumin pretreatment or left untreated, and examined the uterine 
content at 13 days post-transfer (day 18 post-coitus). The implantation ratio in the curcumin-pretreated 
group (24 μM) was significantly lower than that of the untreated control group (Figure 4A). In addition, 
embryos that implanted but failed to develop were subsequently resorbed. Early resorption was 
visualized as small dark moles with no distinct structures, whereas late resorptions resembled placentas 
with no fetal structure. The proportion of implanted embryos that failed to develop normally (early and 
late resorption groups) was significantly higher in the 24 μM curcumin-pretreated group versus the 
control group (Figure 4A). Interestingly, no differences in placental weight were evident between the 
curcumin-treated and untreated groups (Figure 4B), but fetal weight was lower in the curcumin-treated 
group. Moreover, previous and recent experiments by our group reveal that 35–40% of fetuses weigh 
more than 600 mg, with the average weight of total surviving fetuses being ~600 ± 12 mg in the 
untreated control group at day 18 of pregnancy in a mouse embryo transfer assay [27,31-34]. Fetal 
weight is an important indicator of developmental status, and the average fetal weight of the untreated 
control group was thus used as a key indicator for measuring the development status of 
curcumin-treated blastocysts. The results show that only about 11% of the fetuses in the 24 μM 
curcumin-pretreated group weighed more than 600 mg (an indicator of successful embryonic and fetal 
development), in contrast to 44% of control fetuses (Figure 4C). Thus, curcumin exposure at the 
blastocyst stage poses a potential risk to postimplantation development. 
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Figure 4. Effects of curcumin on mouse blastocysts on in vivo implantation, resorption, 
fetal survival and fetal weight. (A) Mouse blastocysts were treated with curcumin (Cur, 6, 
12 or 24 μM) for 24 h or left untreated. Implantations, resorptions and surviving fetuses 
were analyzed, as described in Materials and Methods. The percentage of implantations 
represents the number of implantations per number of transferred embryos × 100. The 
percentage of resorptions or surviving fetuses denotes the number of resorptions or 
surviving fetuses per number of implantations × 100. (B) Placental weights of 40 recipient 
mice were measured. (C) Weight distribution of surviving fetuses on day 18 post-coitus. 
Surviving fetuses were obtained by embryo transfer of control and curcumin-pretreated 
blastocysts, as described in Materials and Methods (320 total blastocysts across   
40 recipients). *** P < 0.001 versus the curcumin-free group. 
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In light of previous reports and our recent finding that ROS effectively induces apoptosis [27,35,36], 
we further used the fluorescent dye DCF-DA to measure the ROS content in curcumin-treated mouse 
blastocyst cells. As shown in Figure 5A, 24 μM curcumin directly induced an increase in fluorescence 
intensity in mouse blastocysts, compared with untreated control cells. Expression changes in Bax and 
Bcl-2 are additionally relevant to the mitochondria-dependent apoptotic pathway [37,38], with high 
and low Bax/Bcl-2 ratios associated with lower and higher apoptotic thresholds, respectively. 
Accordingly, we determined whether curcumin induces apoptosis via modulation of Bax and Bcl-2 
expression. Immunostaining experiments revealed increases and decreases in the Bax and Bcl-2 levels, 
respectively, upon curcumin treatment of mouse blastocysts (Figure 5B). Further investigation of the Int. J. Mol. Sci. 2010, 11                 
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effects of curcumin on mitochondrial membrane potential (MMP) changes in mouse blastocyst cells 
revealed that treatment with 24 μM curcumin suppressed DiOC6(3) uptake into the mitochondria of 
mouse blastocyst cells, indicative of significant MMP loss (Figure 5C). In addition, 24 μM curcumin 
significantly stimulated caspase-3 activation, an important indicator of apoptosis (Figure 5D).   
Figure 5. Effects of curcumin on ROS generation and mitochondria-dependent apoptotic 
processes in mouse blastocysts. Mouse blastocysts were treated with curcumin (Cur, 6, 12 
or 24 μM) or left untreated for 24 h. (A) ROS generation was detected by staining with  
20 μM DCF-DA fluorescence dye. (B) Bax and Bcl-2 expression levels were determined 
by immunostaining with anti-Bax and anti-Bcl-2 antibodies, respectively. The protocol is 
described in “Materials and Methods”. (C) To examine mitochondrial membrane potential 
changes, embryos were incubated with 40 nM DiOC6(3) at 37 °C for 1 h and analyzed 
under a fluorescence microscope. (D) Activation of caspase-3 was analyzed by 
immunostaining with anti-activated caspase-3 antibody for 3 h, followed by a secondary 
antibody conjugated with peroxidase (1:100) for 1 h. Finally, 20 μL of DAB-substrate 
solution was added to embryos, and incubated for 2 min at room temperature. Cells with 
activated caspase-3 are presented in black. 
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Figure 5. Cont. 
 
 
To further determine the role of ROS and apoptotic associated events in curcumin-induced 
apoptosis, we assessed the effects of a commonly used ROS scavenger, N-acetyl cysteine (NAC), as 
well as various caspase-specific inhibitors on curcumin-treated mouse blastocysts. Pretreatment of 
cells with NAC (500 μM) attenuated curcumin-induced apoptosis (Figure 6A). Moreover, pretreatment 
with caspase-9 (Z-LEHD-FMK) and caspase-3 (Z-DEVD-FMK) specific inhibitors effectively blocked 
apoptosis, while the caspase-8 inhibitor Z-IETD-FMK had no effect (Figure 6A). Importantly, 
treatment with 24 μM curcumin was associated with a lower implantation ratio, and failure of further 
development was effectively blocked by NAC and inhibitors of caspase-9 and caspase-3 by embryo 
transfer. The group pretreated with the caspase-8 inhibitor displayed no significant differences 
compared with the untreated control (Figure 6B). In addition, fetal weight was lower in the 24 μM 
curcumin-treated group, which was effectively rescued upon pretreatment with NAC and specific 
caspase-9 and -3 inhibitors (Figure 6C). Based on these data, we suggest that curcumin triggers ROS 
generation, in turn, activating mitochondria-dependent apoptotic processes in mouse blastocyst cells.   
We have previously shown that curcumin induces osteoblast apoptosis at doses of 12.5–25 μM and 
necrosis at doses greater than 50 μM [15]. Interestingly, curcumin is able to both stimulate and inhibit 
apoptotic signaling. For instance, curcumin induces apoptosis in human melanoma (30–60 μM for 24 h) 
[39], human leukemia HL 60 (10–40 μM for 16–24 h) [40,41], AK-5 tumor (10 μM for 18 h) [14,42] 
and MCF-7 breast cancer cells (25￿ μM for 24 h) [43]. Conversely, curcumin (10 μM for 12 h) 
inhibits dexamethane-induced apoptosis in rat thymocytes, chemotherapy-induced apoptosis in breast 
cancer cells [44,45], and methylglyoxal-triggered apoptosis in mouse embryonic stem cells [21]. Our 
novel results, along with previously published findings, indicate that the treatment protocol (i.e., 
(C) Int. J. Mol. Sci. 2010, 11                 
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treatment period and dosage) determines the effects of curcumin on various cell types. Moreover, 
during the complex and precisely orchestrated process of embryonic development, chemical or 
physical injury can affect normal development and lead to malformation or miscarriage of the embryo. 
Thus, it is important to examine the possible teratogenic effects of various agents, including natural 
chemical compounds contained in food that are significant potential apoptotic inducers, such as 
curcumin. In the present study, we investigated whether curcumin adversely affects the blastocyst stage 
of mouse embryos and subsequent early postimplantation embryonic development. We report for the 
first time that treatment with 24 μM curcumin for 24 h induces apoptosis in mouse blastocysts (Figure 
1). Based on this finding, we further analyzed the effects of curcumin on embryonic development by 
incubating blastocysts in medium containing 6, 12 or 24 μM curcumin for 24 h. Our results show that 
curcumin suppresses cell viability in mouse blastocysts via apoptosis (Figures 1 and 2). Dual 
differential staining further showed that this curcumin-induced cell loss and apoptosis occurs primarily in 
the ICM (Figure 2).   
Figure 6. Effects of ROS scavengers and caspase inhibitors on in vivo implantation, 
resorption, fetal survival and fetal weight in curcumin-treated embryos. Mouse blastocysts 
were pretreated with 400 μM N-acetyl cysteine (NAC), 300 μM Z-IETD-FMK (IETD), 
300  μM Z-LEHD-FMK (LEHD) or 300 μM Z-DEVD-FMK (DEVD) for 1 h or left 
untreated. Blastocysts were further incubated with curcumin (Cur, 24 μM) for another 24 h. 
(A) Apoptosis was examined using TUNEL staining, as described in Figure 1.   
(B) Implantations, resorptions and surviving fetuses were analyzed by embryo transfer, as 
described in Materials and Methods and Figure 4. (C) The weight distribution of surviving 
fetuses on day 18 post-coitus. Surviving fetuses were obtained by embryo transfer of 
control and curcumin-pretreated blastocysts (320 total blastocysts across 40 recipients). 
*** P < 0.001 versus the curcumin-free group and #P < 0.001 versus 24 μM 
curcumin-treated group. 
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Figure 6. Cont. 
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The TE arises from the trophoblast at the blastocyst stage and develops into a sphere of epithelial 
cells surrounding the ICM and blastocoel. These cells contribute to the placenta and are required for 
development of the mammalian conceptus [46], indicating that reduction in the TE cell lineage may 
reduce implantation and embryonic viability [47,48]. However, in our experiments, curcumin induced 
cell apoptosis only in the ICM and not TE, and did not have deleterious effects on embryonic 
attachment and outgrowth in vitro. Importantly, we observed a lower implantation rate of 
curcumin-pretreated embryos in the mouse uterus compared with the untreated control group in vivo 
using the embryo transfer assay (Figures 2-4). Previous studies have shown that a ~30% or greater 
reduction in the number of cells in the ICM is associated with high risk of fetal loss or developmental 
injury, even in cases where the implantation rate and TE cell numbers are normal [49]. In addition, the 
ICM cell number is essential for proper implantation, and reduction in this cell lineage may decrease 
embryonic viability [47,48,50]. While apoptosis is responsible for eliminating unwanted cells during 
normal embryonic development, this process does not normally occur at the blastocyst stage [51,52]. 
Excessive apoptosis before or during the blastocyst stage is likely to delete important cell lineages, 
affecting embryonic development and potentially leading to miscarriage or embryonic malformation 
[53]. Thus, in view of the observation that curcumin reduces the cell number and increases apoptosis 
specifically in the ICM of mouse blastocysts, we investigated the possibility that curcumin causes 
embryonic implantation and mortality and/or developmental delay in postimplantation mouse embryos 
in vitro and in vivo (Figure 2). Our results show that curcumin-treated blastocysts suffer from 
decreased embryonic development and increased embryonic death in vitro and implantation in vivo 
(Figures 3 and 4). 
Mechanistically, our data emphasize that curcumin directly evokes intracellular oxidative stress 
(Figure 5A), leading to ROS-mediated apoptosis in mouse blastocyst cells (Figure 6A). In addition, 
these effects seem to involve the mitochondria-dependent apoptotic pathway, as evident from 
curcumin-induced changes in the intracellular levels of Bcl family members (Bax and Bcl-2) and loss 
of mitochondrial membrane potential (Figure 5B). Our findings are consistent with previous data 
showing that curcumin induces apoptosis via activation of the mitochondrial pathway in human 
osteoblasts [15]. Given that recent studies have shown that the addition of specific compounds to Int. J. Mol. Sci. 2010, 11                 
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commonly used cell culture media triggers generation of ROS, such as hydrogen peroxide [54,55], we 
co-incubated curcumin and culture medium, and measured ROS using the ferrous iron 
oxidation-xylenol orange method [54]. No artifactual ROS generation was detected under these 
conditions (data not shown). Importantly, a well-known ROS scavenger, NAC, effectively prevented 
curcumin-induced apoptosis in mouse blastocysts (Figure 6A). We further determined the precise 
mechanisms of curcumin-triggered apoptosis in mouse blastocysts (Figures 5 and 6). Our results 
collectively demonstrate that curcumin triggers apoptosis in ICM cells of mouse blastocysts, leading to 
impairment of embryo development via ROS generation, which stimulates downstream processes 
through the mitochondria-dependent pathway. 
3. Experimental Section 
3.1. Chemicals   
Curcumin, Pregnant mare’s serum gonadotropin (PMSG), Bovine serum albumin (BSA), sodium 
pyruvate and puerarin were purchased from Sigma (St. Louis, MO, USA). Human chorionic 
gonadotropin (hCG) was obtained from Serono (NV Organon Oss, the Netherlands). The TUNEL in 
situ cell death detection kit was obtained from Roche (Mannheim, Germany) and CMRL-1066 
medium was from Gibco Life Technologies (Grand Island, NY, USA). Z-DEVD-FMK, Z-LEHD-FMK 
and Z-IETD-FMK were from Calbiochem (La Jolla, CA, USA). 
3.2. Collection of Mouse Morulas and Blastocysts 
ICR mice were from National Laboratory Animal Center (Taiwan, ROC). This research was also 
approved by the Animal Research Ethics Board of Chung Yuan Christian University (Taiwan, ROC). 
All animals received humane care, as outlined in the Guidelines for Care and Use of Experimental 
Animals (Canadian Council on Animal Care, Ottawa, 1984). All mice were maintained on breeder 
chow (Harlan Teklad chow) with food and water available ad libitum. Housing was in standard 
28 cm × 16  cm × 11  cm  (height)  polypropylene  cages with wire-grid tops and kept under a 
12 h day/12 h night regimen. Nulliparous females (6-8 weeks old) were superovulated by injection of 
5 IU PMSG followed 48 hours later by injection of 5 IU hCG, and then mated overnight with a single 
fertile male of the same strain. The day a vaginal plug was found was defined as day 0 of gestation. 
Plug-positive females were separated for experimentation. Morulas were obtained by flushing the 
uterine tubes on the afternoon of gestation day 3, and blastocysts were obtained by flushing the uterine 
horn on day 4; in both cases the flushing solution consisted of CMRL-1066 culture medium containing 
1 mM glutamine and 1 mM sodium pyruvate. The concentration of glucose in this medium was 5 mM. 
Expanded blastocysts from different females were pooled and randomly selected for experiments.   
3.3. Curcumin Treatment and TUNEL Assay 
Blastocysts were incubated in medium containing with or without 6, 12, or 24 μM curcumin for 
24 h. For apoptosis detection, embryos were washed in curcumin-free medium, fixed, permeabilized Int. J. Mol. Sci. 2010, 11                 
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and subjected to TUNEL labeling using an in situ cell death detection kit (Roche Molecular 
Biochemicals, Mannheim, Germany) according to the manufacturer’s protocol. Photographic images 
were taken under brightfield illumination using a fluorescence microscope. 
3.4. Curcumin Treatment and Cell Proliferation 
Blastocysts were incubated with or without culture medium containing indicated concentrations of 
curcumin (6-24 μM) for 24 h. And then, blastocysts were washed with curcumin-free medium and dual 
differential staining was used to facilitate counting of cell numbers in the inner cell mass (ICM) and 
trophectoderm (TE) [47]. Blastocysts were incubated in 0.4% pronase in M2–BSA medium (M2 
medium containing 0.1% bovine serum albumin) for removal of the zona pellucida. The denuded 
blastocysts were exposed to 1 mM trinitrobenzenesulphonic acid (TNBS) in BSA-free M2 medium 
containing 0.1% polyvinylpyrrolidone (PVP) at 4 °C for 30 min, and then washed with M2 medium 
(Sigma) [56]. The blastocysts were further treated with 30 μg/mL anti-dinitrophenol-BSA complex 
antibody in M2-BSA at 37 °C for 30 min, and then with M2 medium supplemented with 10% whole 
guinea-pig serum as a source of complement, along with 20 μg/mL bisbenzimide and 10 μg/mL 
propidium iodide (PI), at 37 °C for 30 min. The immunolysed blastocysts were gently transferred to 
slides and protected from light before observation. Under UV light excitation, the ICM cells (which 
take up bisbenzimidine but exclude PI) appeared blue, whereas the TE cells (which take up both 
fluorochromes) appeared orange-red. Since multinucleated cells are not common in preimplantation 
embryos [57], the number of nuclei was considered to represent an accurate measure of the  
cell number. 
3.5. Annexin V Staining 
Blastocysts were incubated in 0, 6, 12 or 24 μM curcumin for 24 h, washed with curcumin-free 
culture medium, and then stained using an Annexin V-FLUOS staining kit (Roche), according to the 
manufacturer's instructions. Briefly, the blastocysts were incubated in M2-BSA for removal of the zona 
pellucida, washed with PBS plus 0.3% BSA, and then incubated for 60 min with a mixture of 100 μL 
binding buffer, 1 μL fluorescein isothiocyanate (FITC)-conjugated Annexin V and 1 μL PI. After 
incubation, the embryos were washed and photographed using a fluorescence microscope under 
fluorescent illumination. Cells staining Annexin V+/PI- were considered apoptotic, while those 
staining Annexin V+/PI+ were considered necrotic.   
3.6. Morphological Analysis of Embryonic Development 
Blastocysts were cultured according to a modification of the previously reported method [58]. 
Briefly, embryos were cultured in 4-well multidishes at 37 °C. For group culture, four embryos were 
cultured per well. The basic medium consisted of CMRL-1066 supplemented with 1 mM glutamine 
and 1 mM sodium pyruvate plus 50 IU/mL penicillin and 50 mg/mL streptomycin (hereafter called 
culture medium). For treatments, the embryos were incubated with 0, 6, 12 or 24 μM curcumin for Int. J. Mol. Sci. 2010, 11                 
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24 h. Thereafter, the embryos were cultured for 3 days in culture medium supplemented with 20% fetal 
calf serum, and for 4 days in culture medium supplemented with 20% heated-inactivated human 
placental cord serum, for a total culture time of 8 days from the onset of treatment. Embryos were 
inspected daily under a phase-contrast dissecting microscope, and developmental stages were 
classified according to established methods [59,60]. Under these culture conditions, each hatched 
blastocyst attached to the fibronectin and grew to form a cluster of ICM cells over the trophoblastic 
layer via in a process called TE outgrowth. After a total incubation period of 96 h, morphological 
scores for outgrowth were estimated. Growing embryos were classified as either ‘attached’ or 
‘outgrowth’, with the latter defined by the presence of a cluster of ICM cells over the trophoblastic 
layer. As described previously [61], ICM clusters were scored according to shape, ranging from 
compact and rounded ICM (+++) to a few scattered cells (+) over the trophoblastic layer.   
3.7. Blastocyst Development Following Embryo Transfer 
To examine the ability of expanded blastocysts to implant and develop in vivo, the generated 
embryos were transferred to recipient mice. ICR females (white skin color) were mated with 
vasectomized males (C57BL/6J; black skin color; from National Laboratory Animal Center, Taiwan, 
ROC) to produce pseudopregnant dams as recipients for embryo transfer. To ensure that all fetuses in 
the pseudopregnant mice came from embryo transfer (white color) and not from fertilization by 
C57BL/6J (black color), we examined the skin color of the fetuses at day 18 post-coitus. To assess the 
impact of curcumin on postimplantation growth in vivo, blastocysts were exposed to 0, 6, 12 and 
24 μM curcumin for 24 h, and then 8 embryos were transferred in parallel to the paired uterine horns 
of day 4 pseudopregnant mice. The surrogate mice were killed on day 18 post-coitus, and the 
frequency of implantation was calculated as the number of implantation sites per number of embryos 
transferred. The incidence rates of resorbed and surviving fetuses were calculated as the number of 
resorptions or surviving fetuses, respectively, per number of implantations. The weights of the 
surviving fetuses and placentae were measured immediately after dissection. 
3.8. Immunofluorescent Embryo Stain 
Mouse blastocyst cells were fixed by formaldehyde, permeabilized by Triton X-100, blocked by 
bovine serum albumin (5 mg/mL in PBS), and incubated with anti-Bax or anti-Bcl-2 antibodies 
(40 mg/mL) at room temperature for 3 h. After washing three times with PBS, embryos were incubated 
with second antibody conjugated with FITC or Rhodamine (TRITC) (1:100) at room temperature for 
1 h and then observed under a fluorescence microscope. 
3.9. Statistics 
The data were analyzed using one-way ANOVA and t-tests and are presented as the mean ± SEM, 
with significance at P < 0.05. 
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4. Conclusions 
In summary, we show for the first time that curcumin induces apoptosis only in the ICM of mouse 
blastocysts through ROS- and mitochondria-dependent pathways, leading to decreased embryonic 
development and viability. These findings imply that curcumin is a potential hazardous risk factor for 
normal embryonic development. 
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